celecoxib has been researched along with Systemic Inflammatory Response Syndrome in 1 studies
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with Molsidomine reduced mortality to 0%, decreased BT, MPO, pro-inflammatory cytokines and OFR (p<." | 1.43 | Comparative study of bacterial translocation control with nitric oxide donors and COX2 inhibitor. ( García-Cenador, MB; García-Criado, FJ; García-García, MI; García-Moro, M; García-Sánchez, E; García-Sánchez, JE; Lorenzo-Gómez, MF; Lozano-Sánchez, F; Sánchez-Conde, MP, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Cenador, MB | 1 |
Lorenzo-Gómez, MF | 1 |
García-Moro, M | 1 |
García-García, MI | 1 |
Sánchez-Conde, MP | 1 |
García-Criado, FJ | 1 |
García-Sánchez, E | 1 |
Lozano-Sánchez, F | 1 |
García-Sánchez, JE | 1 |
1 other study available for celecoxib and Systemic Inflammatory Response Syndrome
Article | Year |
---|---|
Comparative study of bacterial translocation control with nitric oxide donors and COX2 inhibitor.
Topics: Animals; Bacterial Translocation; Celecoxib; Cyclooxygenase 2 Inhibitors; Male; Molsidomine; Nitric | 2016 |